🇺🇸 FDA
Pipeline program

Symbicort Turbuhaler 160/4.5

D5890L00027

Approved small_molecule completed

Quick answer

Symbicort Turbuhaler 160/4.5 for Asthma is a Approved program (small_molecule) at AstraZeneca with 1 ClinicalTrials.gov record(s).

Program details

Company
AstraZeneca
Indication
Asthma
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials